Repeated intravitreal injection of bevacizumab for clinically significant diabetic macular edema

Retina

Volumn 28, Issue 9, 2008, Pages 1314-1318

  Roh, Mi In ^a   Byeon, Suk Ho ^a   Kwon, Oh Woong ^a,b  

^a Kyung Hee University Hospital   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Clinically significant diabetic macular edema; Intravitreal bevacizumab injection

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY; RECURRENT DISEASE; SIDE EFFECT; STUDENT T TEST; THICKNESS; TREATMENT OUTCOME; VISUAL ACUITY; DIABETIC RETINOPATHY; DRUG EFFECT; HOSPITALIZATION; INJECTION; MIDDLE AGED; PATHOLOGY; RETINA MACULA EDEMA; RETINA MACULA LUTEA; RETREATMENT; TIME; VITREOUS BODY;

AGED; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; FEMALE; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; RETREATMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY;

EID: 63549146725     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181853d2a     Document Type: Article

References (16)

1. Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to agerelated macular degeneration. Retina 2006;26:383-390.
2. Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2006;26:495-511.
3. Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
4. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, et al. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007;114: 743-750.
5. Hsu J, Kaiser RS, Sivalingam A, et al. Intravitreal bevacizumab (Avastin) in central retinal vein occlusion. Retina 2007; 27:1013-1019.
6. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:336-339.
7. Priglinger SG, Wolf AH, Kreutzer TC, et al. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina 2007;27: 1004-1012.
8. Stewart MW. Predicted biologic activity of intravitreal bevacizumab. Retina 2007;27:1196-1200.
9. Bakri SJ, Snyder MR, Reid JM, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 2007;114: 855-859.
10. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806.
11. Paccola L, Costa RA, Folgosa MS, et al. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br J Ophthalmol 2008;92: 76-80.
12. Audren F, Lecleire-Collet A, Erginay A, et al. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg. Am J Ophthalmol 2006;142:794-799.
13. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
14. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-224.
15. Gillies MC, Islam FM, Zhu M, et al. Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. Br J Ophthalmol 2007;91:1323-1326.
16. Chan CK, Mohamed S, Shanmugam MP, et al. Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema. Br J Ophthalmol 2006;90:1137-1141.